The Association of American Medical Colleges (AAMC) and the American Hospital Association (AHA) filed separate comment letters this week targeting the 340B fight — AAMC on CMS’s Medicare Drug Price Negotiation Program rule, AHA on Sen. Bill Cassidy’s 340B Drug…

The FDA has approved Rasonque (daraxonrasib) for adults with advanced pancreatic cancer that has stopped responding to earlier treatment, or for patients too sick for standard combination chemotherapy. The drug improved median overall survival to 13.2 months compared with just…

CMS is investing $3.15 million to strengthen pharmacy connectivity and care coordination across Ohio’s 73 rural counties through the Rural Health Transformation Program. The funding will connect independent and retail pharmacies, federally qualified health centers and outpatient hospital pharmacies to…

Vitruvias Therapeutics is voluntarily recalling one lot of Thyroid Tablets, USP 30 milligrams after testing found the product could be more potent than intended. The consumer-level recall covers Lot 504950, which was distributed nationwide to Vitruvias Therapeutics’ direct accounts from…

The FDA has approved new first-line treatment options for adults with certain HER2-positive gastric, gastroesophageal junction and esophageal cancers. The agency approved Ziihera in combination with Tevimbra and fluoropyrimidine- and platinum-containing chemotherapy for adults with HER2-positive, unresectable, locally advanced or…

The FDA cleared Amygdala Neurosciences’ Investigational New Drug application for ANS-858, allowing the company to move the drug into clinical development. ANS-858 is a selective, reversible, orally bioavailable inhibitor of aldehyde dehydrogenase 2 (ALDH2), according to an Aug. 18 news release from…

Tampa, Fla.-based Moffitt Cancer Center has launched a radiopharmaceutical program at its Land O’ Lakes, Fla.-based research facility and medical campus, Speros. The program will focus on radiopharmaceutical research, development, clinical translation and manufacturing. The program will be led by…

Pediatric medications have more active FDA-listed shortages than any other therapeutic category, according to the FDA’s drug shortage database. Here are the categories with the most active shortage listings, ranked by number of active shortages as of Aug. 25: 1.…

OhioHealth Morrow County Hospital in Mount Gilead, Ohio, is switching its automated dispensing cabinets to Omnicell as part of the health system’s broader push to improve medication safety. The upgrade allows any OhioHealth hospital to view the medications available at…

Mark Cuban Cost Plus Drug Co. has partnered with RxSaveCard and nonprofit Golden Thread to streamline sourcing and reduce costs of pediatric cancer clinical trial medications.  Once enrolled in a study, patients will sign up for RxSaveCard and receive trial…